10 Firms Fall Amid Disappointing Earnings Performance

8. Moderna Inc. (NASDAQ:MRNA)

Shares of pharmaceutical giant Moderna declined by 6.51 percent on Tuesday to end at $34.17 per share as analysts pointed to Robert F. Kennedy Jr.’s advancement in his nomination as secretary for Health and Human Services as having weighed down investor sentiment.

Just recently, the Senate voted in favor of Kennedy’s nomination as the department’s secretary, sparking fears among investors over his anti-vaccine stance. Despite his denial, Kennedy was said to be a prominent figure in the anti-vaccine movement, raising doubts about vaccine safety and efficacy.

If confirmed, Kennedy would be responsible for managing the department’s $3 trillion in healthcare spending and overseeing health insurance for hundreds of millions of Americans.